Source: Annual Congress 2009 - Occupational exposures and disease II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Barbinova, X. Baur, M. Oldenburg (Hamburg, Germany). MCS patients have decreased FeNO. Eur Respir J 2009; 34: Suppl. 53, 1068

Member's Comments

No comment yet.

Related content which might interest you: FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 The relationship between fractional exhaled nitric oxide and asthma symptom scores in patients on mepolizumab Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 FeNO Source: Annual Congress 2009 - PG11 Paediatric lung function testing - an interactive course Year: 2009 8-Isoprostane and FeNO levels in IPF and sarcoidosis patients (Preliminary results) Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Diagnostic value of FeNO in COPD and asthma - COPD overlap syndrome Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 The correlation between the Borg score and VAS and lung function parameters in patients with asthma and COPD Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010 Isocyanate-induced increase of exhaled NO (FeNO) Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 The relationship between symptom scores and medication adherence in stable COPD patients Source: International Congress 2017 – COPD management Year: 2017 FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Regarding the role of FENO in predicting failure after ICS reduction in mild-to-moderate asthma patients Source: Eur Respir J, 56 (2) 2002375; 10.1183/13993003.02375-2020 Year: 2020 Correlations between SGRQ and other clinical and functional parameters in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 809s Year: 2006 Factors associated with high levels of exhaled NO in children using asthma medication Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011 FeNO in relation to asthma control in steroid treated asthmatics Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Do changes in spirometric indices and FeNO predict asthma outcomes in children? An individual patient data analysis using results from seven FeNO trials Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018 Low hematocrit as predictor of exacerbation frequency in COPD patients Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010